[Behavioural and psychological symptoms of dementia (BPSD): pharmacological management].
BPSD affect all demented patients during their illness. They are part of the process of the disease and can be correlated to neurotransmitter dysfunctions as well as to the coping difficulties due to the patient's cognitive decline. The major consequences of BPSD are a decreased quality of life of both patient and caregivers and an increased need of professional care. Physicians should exclude precipitating factors such as intercurrent somatic, psychiatric or drug-related problems first and then proceed with behavioural or environment therapy. Introduction of a pharmacological treatment should be the last resort. This systematic review discusses the causes and consequences of BPSD and focuses on the evidence-based pharmacological approach. Only three drugs can be recommended at the present time: risperidone, olanzapine and donepezil.